Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug-resistant strains of the illness.
Researchers at the University of Otago have discovered new treatment possibilities for antibiotic-resistant tuberculosis (TB) strains, clearing the path for new tactics to tackle the disease that takes the lives of around 4,000 people every day.
New treatment options for tuberculosis (TB) strains that are resistant to antibiotics have been found by University of Otago researchers, paving the way for fresh strategies to combat the illness that claims the lives of approximately 4,000 people daily.
According to the IIT Roorkee statement, the molecule, discovered after a rigorous screening process, has shown potent antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria, including some of the most problematic drug-resistant strains.
Washington [US], July 28 (ANI): The leading infectious disease around the world, tuberculosis, which affects around 25% of the world's population, is still caused by Mycobacterium tuberculosis. Drug-resistant strains have made it difficult to treat infections, but professor Helen Zgurskaya
Washington D.C. [USA], Dec 25 (ANI): Staph bacteria are mostly feared for drug-resistant strains, which are becoming a serious threat to public health because they are the leading cause of potentially dangerous skin diseases. Attempts to establish a Staphylococcus aureus methicillin-resistan